Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-10-01 9:23 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN ALAIN J Director 10% Owner |
0 | $0 | 4,212,318 (Indirect) |
View |
Ownership |
2020-10-01 9:22 pm |
N/A 2030-07-02 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
0 | $0 | 296,321 (Direct) |
View |
Ownership |
2020-10-01 9:21 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
0 | $0 | 23,240 (Direct) |
View |
Ownership |
2020-10-01 9:18 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Prokupets Elena Director |
0 | $0 | 720,008 (Indirect) |
View |
Ownership |
2020-10-01 9:16 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
0 | $0 | 295,576 (Direct) |
View |
Ownership |
2020-10-01 9:16 pm |
N/A 2029-04-08 |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
0 | $0 | 444,480 (Direct) |
View |
Ownership |
2020-10-01 9:14 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | DOWNEY BRUCE Director |
0 | $0 | 498,103 (Direct) |
View |
Ownership |
2020-10-01 9:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Chief Executive Officer 10% Owner |
0 | $0 | 4,340,377 (Indirect) |
View |
Ownership |
2020-10-01 9:10 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Wahlberg Laura Jean See Remarks |
0 | $0 | 37,645 (Direct) |
View |
Ownership |
2020-10-01 9:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
0 | $0 | 444,478 (Direct) |
View |
Ownership |
2020-10-01 9:08 pm |
N/A 2030-07-02 |
C4 Therapeutics Inc. | CCCC | MCKEE WILLIAM Chief Financial Officer |
0 | $0 | 296,321 (Direct) |
View |